TFF PharmaceuticalsTFFP
13F holders, Q2 2024 (June 30)21holders +2
4new positions
2sold out
1famous investor
$1.66avg. 13F price*
At the end of Q2 2024, 21 institutions reported holding TFF Pharmaceuticals Inc. (TFFP) in their 13F filings, up 2 from Q1 2024. 4 opened new positions and 2 sold out. The largest holders were Carlson Capital, L.P. ($487K), Armistice Capital, LLC ($308K) and Westside Investment Management, Inc. ($84K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- TFF Pharmaceuticals Inc.
- CUSIP
- 87241J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $327K |
| Exits | 2 | $3K |
All 13F filers, Q1 2024 → Q2 2024: 317,996 shares bought and 24,411 shares sold, net +293,585 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Carlson Capital, L.P. | 0.08% | Add +51.3% | 293,460 | $487K |
| Armistice Capital, LLC | 0.01% | New | 185,695 | $308K |
| Westside Investment Management, Inc. | 0.02% | Add +28.7% | 50,491 | $84K |
| DRW Securities, LLC | 0.00% | No change | 40,000 | $66K |
| Geode Capital Management, LLC | 0.00% | Add +25.7% | 21,798 | $36K |
| Renaissance Technologies | 0.00% | Add +12.0% | 14,777 | $25K |
| Vanguard Group Inc. | 0.00% | Reduce -65.1% | 12,136 | $20K |
| Nwam LLC | 0.01% | New | 10,240 | $17K |
| BlackRock Inc. | 0.00% | Reduce -7.9% | 7,186 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +882.5% | 4,932 | $8K |
| University of Texas/Texas Am Investment Management Co. | 0.00% | No change | 882 | $1K |
| ORG Partners LLC | 0.00% | New | 740 | $1K |
| UBS Group AG | 0.00% | Reduce -34.8% | 735 | $1K |
| Gen-Wealth Partners Inc | 0.00% | No change | 100 | $166 |
| Raleigh Capital Management Inc. | 0.00% | New | 91 | $151 |
| Wells Fargo & Company | 0.00% | Reduce -21.8% | 61 | $101 |
| HM Payson & Co. | 0.00% | No change | 60 | $100 |
| Osaic Holdings, Inc. | 0.00% | No change | 40 | $66 |
| Morgan Stanley | 0.00% | No change | 32 | $53 |
| Bank of America Corp. | 0.00% | Reduce -34.3% | 23 | $38 |
| Royal Bank of Canada | 0.00% | Reduce -68.0% | 156 | $0 |
"% of holder's portfolio" is TFFP's weight in each manager's 13F, not the share of TFF Pharmaceuticals Inc. the manager owns.